Reclaiming Recovery: Building a Successful

Vivistim^®Therapy™ Program

March 10, 2026

Original Air Date

On-Demand Webinar

Guest Speakers:

Kelsey Harris, PT, DPT, CSRS, CNS

CEO and Founder

NeuroAxis Rehabilitation Services

This webinar explores how an outpatient neurorehabilitation program integrated Vivistim Paired VNS™ Therapy into its existing, outcomes-driven stroke rehab approach, with practical insights on documentation, program awareness, and outcome tracking.

Topics for Discussed

Overview of Vivistim Paired VNS Therapy and clinical rationale for integrating it into an established neurorehabilitation model
Documentation strategies
Program awareness and referral-building strategies
Review of real-world clinical outcomes and lessons learned

Kelsey is a neurologic physical therapist, entrepreneur, and educator passionate about reimagining how neurological rehabilitation is delivered. A graduate of Duquesne University, she completed dual degrees in Biology and Health Sciences before earning her Doctorate of Physical Therapy in 2016.

While working across inpatient and outpatient settings, Kelsey discovered that the most meaningful outcomes for the neurologic population came from individualized treatment and real-world, home-based practice. This realization led her to launch NeuroAxis Rehabilitation Services in 2021—now a 22+ member interdisciplinary team providing mobile outpatient neurological care built around patient goals, environment, and lived experience.

Kelsey also serves as an adjunct professor in Duquesne University’s Physical Therapy Program, where she enjoys mentoring future clinicians and advancing holistic rehabilitation approaches.

Watch
On-Demand Now!

Please complete this form for access to the webinar.

The MicroTransponder^® Vivistim^® Paired VNS^™ System is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. Do not use if the patient has had a bilateral or left cervical vagotomy. Risks may include, but are not limited to pain after surgery, hoarseness, bruising, swelling, coughing and throat irritation. Infection leading to explant is a risk associated with any device surgery. For full safety information, please see www.vivistim.com/safety. Individual results may vary.